Pro-inflammatory cytokines mediate the epithelial-to-mesenchymal-like transition of pediatric posterior fossa ependymoma.
Rachael G AubinEmma C TroisiJavier MontelongoAdam N AlghalithMac Lean P NasrallahMariarita SantiPablo G CámaraPublished in: Nature communications (2022)
Pediatric ependymoma is a devastating brain cancer marked by its relapsing pattern and lack of effective chemotherapies. This shortage of treatments is due to limited knowledge about ependymoma tumorigenic mechanisms. By means of single-nucleus chromatin accessibility and gene expression profiling of posterior fossa primary tumors and distal metastases, we reveal key transcription factors and enhancers associated with the differentiation of ependymoma tumor cells into tumor-derived cell lineages and their transition into a mesenchymal-like state. We identify NFκB, AP-1, and MYC as mediators of this transition, and show that the gene expression profiles of tumor cells and infiltrating microglia are consistent with abundant pro-inflammatory signaling between these populations. In line with these results, both TGF-β1 and TNF-α induce the expression of mesenchymal genes on a patient-derived cell model, and TGF-β1 leads to an invasive phenotype. Altogether, these data suggest that tumor gliosis induced by inflammatory cytokines and oxidative stress underlies the mesenchymal phenotype of posterior fossa ependymoma.
Keyphrases
- genome wide
- transcription factor
- genome wide identification
- bone marrow
- stem cells
- oxidative stress
- single cell
- dna methylation
- cell therapy
- copy number
- multiple sclerosis
- dna damage
- transforming growth factor
- signaling pathway
- healthcare
- poor prognosis
- rheumatoid arthritis
- inflammatory response
- white matter
- gene expression
- minimally invasive
- electronic health record
- papillary thyroid
- immune response
- epithelial mesenchymal transition
- machine learning
- resting state
- neuropathic pain
- disease activity
- induced apoptosis
- dna binding
- anti inflammatory
- functional connectivity
- brain injury
- nuclear factor
- diabetic rats